147 related articles for article (PubMed ID: 27161300)
1. SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.
Pan Z; Jing W; He K; Zhang L; Long X
Cell Physiol Biochem; 2016; 38(5):1975-83. PubMed ID: 27161300
[TBL] [Abstract][Full Text] [Related]
2. Expression of SATB1 and HER2 in gastric cancer and its clinical significance.
Yuan CL; Li L; Zhou X; Liz H; Han L
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2256-64. PubMed ID: 27338049
[TBL] [Abstract][Full Text] [Related]
3. Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study.
Kobierzycki C; Wojnar A; Dziegiel P
Folia Histochem Cytobiol; 2013; 51(4):333-8. PubMed ID: 24497139
[TBL] [Abstract][Full Text] [Related]
4. SATB1 overexpression correlates with gastrointestinal neoplasms invasion and metastasis: a meta-analysis for Chinese population.
Xiao T; Fu L; Jie Z
Oncotarget; 2017 Jul; 8(29):48282-48290. PubMed ID: 28636989
[TBL] [Abstract][Full Text] [Related]
5. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of SATB1 in the development of breast cancer.
Zhang S; Gao X; Ma Y; Jiang J; Dai Z; Yin X; Min W; Hui W; Wang B
Genet Mol Res; 2015 Apr; 14(2):3309-17. PubMed ID: 25966097
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
8. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.
Xu F; Li M; Zhang C; Cui J; Liu J; Li J; Jiang H
Oncotarget; 2017 Jan; 8(4):6003-6012. PubMed ID: 27999206
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of SATB1 in gastrointestinal cancer: a meta-analysis and literature review.
Zhang S; Tong YX; Xu XS; Lin H; Chao TF
Oncotarget; 2017 Jul; 8(29):48410-48423. PubMed ID: 28430598
[TBL] [Abstract][Full Text] [Related]
11. SATB1 gene expression and breast cancer prognosis.
Hanker LC; Karn T; Mavrova-Risteska L; Ruckhäberle E; Gaetje R; Holtrich U; Kaufmann M; Rody A; Wiegratz I
Breast; 2011 Aug; 20(4):309-13. PubMed ID: 20980149
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
13. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer.
Yamayoshi A; Yasuhara M; Galande S; Kobori A; Murakami A
Oligonucleotides; 2011; 21(2):115-21. PubMed ID: 21500976
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
16. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
[TBL] [Abstract][Full Text] [Related]
19. Is SATB1 a master regulator in breast cancer growth and metastasis?
Zheng J
Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]